Friday, October 31, 2014

VolitionRx Initiates Sponsorship of Two-time Cancer Survivor to Drive Awareness for the Importance of Early Cancer Detection | Publicwire


VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests, today announced that it has initiated sponsorship of Sean Swarner, the first cancer survivor to summit Mt. Everest, to raise awareness of the importance of early detection of cancer.
http://bit.ly/107LlXI

No comments:

Post a Comment